312 related articles for article (PubMed ID: 35935969)
21. Ubiquitin-specific peptidase 22 in cancer.
Feng T; Ling S; Xu C; Ying L; Su D; Xu X
Cancer Lett; 2021 Aug; 514():30-37. PubMed ID: 33989708
[TBL] [Abstract][Full Text] [Related]
22. Aggregation of Polyglutamine-expanded Ataxin 7 Protein Specifically Sequesters Ubiquitin-specific Protease 22 and Deteriorates Its Deubiquitinating Function in the Spt-Ada-Gcn5-Acetyltransferase (SAGA) Complex.
Yang H; Liu S; He WT; Zhao J; Jiang LL; Hu HY
J Biol Chem; 2015 Sep; 290(36):21996-2004. PubMed ID: 26195632
[TBL] [Abstract][Full Text] [Related]
23. Targeting CD26 suppresses proliferation of malignant mesothelioma cell via downmodulation of ubiquitin-specific protease 22.
Okamoto T; Yamazaki H; Hatano R; Yamada T; Kaneko Y; Xu CW; Dang NH; Ohnuma K; Morimoto C
Biochem Biophys Res Commun; 2018 Oct; 504(2):491-498. PubMed ID: 30197002
[TBL] [Abstract][Full Text] [Related]
24. The ubiquitin hydrolase USP22 contributes to 3'-end processing of JAK-STAT-inducible genes.
Chipumuro E; Henriksen MA
FASEB J; 2012 Feb; 26(2):842-54. PubMed ID: 22067483
[TBL] [Abstract][Full Text] [Related]
25. USP22 acts as an oncogene by regulating the stability of cyclooxygenase-2 in non-small cell lung cancer.
Xiao H; Tian Y; Yang Y; Hu F; Xie X; Mei J; Ding F
Biochem Biophys Res Commun; 2015 May; 460(3):703-8. PubMed ID: 25817787
[TBL] [Abstract][Full Text] [Related]
26. Ubiquitin-specific protease 22 is associated with poor prognosis in neuroblastoma.
Zhibo Q; Lianxin L
Adv Clin Exp Med; 2020 Mar; 29(3):295-300. PubMed ID: 32216173
[TBL] [Abstract][Full Text] [Related]
27. A protein sequence-based deep transfer learning framework for identifying human proteome-wide deubiquitinase-substrate interactions.
Liu Y; Li D; Zhang X; Xia S; Qu Y; Ling X; Li Y; Kong X; Zhang L; Cui CP; Li D
Nat Commun; 2024 May; 15(1):4519. PubMed ID: 38806474
[TBL] [Abstract][Full Text] [Related]
28. Ubiquitin-specific protease 22 is critical to in vivo angiogenesis, growth and metastasis of non-small cell lung cancer.
Zhang K; Yang L; Wang J; Sun T; Guo Y; Nelson R; Tong TR; Pangeni R; Salgia R; Raz DJ
Cell Commun Signal; 2019 Dec; 17(1):167. PubMed ID: 31842906
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of ubiquitin-specific protease 22 predicts poor survival in patients with early-stage non-small cell lung cancer.
Ning J; Zhang J; Liu W; Lang Y; Xue Y; Xu S
Eur J Histochem; 2012 Nov; 56(4):e46. PubMed ID: 23361242
[TBL] [Abstract][Full Text] [Related]
30. Increased expression of ubiquitin-specific protease 22 can promote cancer progression and predict therapy failure in human colorectal cancer.
Liu YL; Yang YM; Xu H; Dong XS
J Gastroenterol Hepatol; 2010 Nov; 25(11):1800-5. PubMed ID: 21039844
[TBL] [Abstract][Full Text] [Related]
31. USP22 promotes resistance to EGFR-TKIs by preventing ubiquitination-mediated EGFR degradation in EGFR-mutant lung adenocarcinoma.
Zhang H; Han B; Lu H; Zhao Y; Chen X; Meng Q; Cao M; Cai L; Hu J
Cancer Lett; 2018 Oct; 433():186-198. PubMed ID: 29981430
[TBL] [Abstract][Full Text] [Related]
32. Role of ubiquitin specific proteases in the immune microenvironment of prostate cancer: A new direction.
Guo J; Zhao J; Sun L; Yang C
Front Oncol; 2022; 12():955718. PubMed ID: 35924159
[TBL] [Abstract][Full Text] [Related]
33. The ubiquitin-specific peptidase 22 is a deubiquitinase of CD73 in breast cancer cells.
Gregory S; Xu Y; Xie P; Fan J; Gao B; Mani N; Iyer R; Tang A; Wei J; Chaudhuri SM; Wang S; Liu H; Zhang B; Fang D
Am J Cancer Res; 2022; 12(12):5564-5575. PubMed ID: 36628293
[TBL] [Abstract][Full Text] [Related]
34. Ubiquitin-specific protease 22: a novel molecular biomarker in glioma prognosis and therapeutics.
Liang J; Zhang X; Xie S; Zhou X; Shi Q; Hu J; Wang W; Qi W; Yu R
Med Oncol; 2014 Apr; 31(4):899. PubMed ID: 24573640
[TBL] [Abstract][Full Text] [Related]
35. USP22 knockdown enhanced chemosensitivity of hepatocellular carcinoma cells to 5-Fu by up-regulation of Smad4 and suppression of Akt.
Zhang J; Luo N; Tian Y; Li J; Yang X; Yin H; Xiao C; Sheng J; Li Y; Tang B; Li R
Oncotarget; 2017 Apr; 8(15):24728-24740. PubMed ID: 28445968
[TBL] [Abstract][Full Text] [Related]
36. EZH2 Inhibition Enhances PD-L1 Protein Stability Through USP22-Mediated Deubiquitination in Colorectal Cancer.
Huang J; Yin Q; Wang Y; Zhou X; Guo Y; Tang Y; Cheng R; Yu X; Zhang J; Huang C; Huang Z; Zhang J; Guo Z; Huo X; Sun Y; Li Y; Wang H; Yang J; Xue L
Adv Sci (Weinh); 2024 Mar; ():e2308045. PubMed ID: 38520088
[TBL] [Abstract][Full Text] [Related]
37. Ubiquitin-specific peptidase 22, a histone deubiquitinating enzyme, is a novel poor prognostic factor for salivary adenoid cystic carcinoma.
Dai W; Yao Y; Zhou Q; Sun CF
PLoS One; 2014; 9(1):e87148. PubMed ID: 24466336
[TBL] [Abstract][Full Text] [Related]
38. USP22-dependent HSP90AB1 expression promotes resistance to HSP90 inhibition in mammary and colorectal cancer.
Kosinsky RL; Helms M; Zerche M; Wohn L; Dyas A; Prokakis E; Kazerouni ZB; Bedi U; Wegwitz F; Johnsen SA
Cell Death Dis; 2019 Dec; 10(12):911. PubMed ID: 31801945
[TBL] [Abstract][Full Text] [Related]
39. USP22 is useful as a novel molecular marker for predicting disease progression and patient prognosis of oral squamous cell carcinoma.
Piao S; Liu Y; Hu J; Guo F; Ma J; Sun Y; Zhang B
PLoS One; 2012; 7(8):e42540. PubMed ID: 22880026
[TBL] [Abstract][Full Text] [Related]
40. USP22 promotes epithelial-mesenchymal transition via the FAK pathway in pancreatic cancer cells.
Ning Z; Wang A; Liang J; Xie Y; Liu J; Yan Q; Wang Z
Oncol Rep; 2014 Oct; 32(4):1451-8. PubMed ID: 25070659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
